Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ocumension Therapeutics | 5DG | May 16, 2024 | 0.80 | -0.63 |
Oncimmune Holdings plc | OCY | May 16, 2024 | 0.22 | -3.54 |
Oncoarendi Therapeutics SA | 1B1 | May 16, 2024 | 3.37 | -4.27 |
Oncotherpapy Science Inc | 30O | May 16, 2024 | 0.07 | -7.69 |
Open Orphan plc | CRO | May 16, 2024 | 0.30 | -1.31 |
Opthea Limited | UKJ | May 16, 2024 | 0.40 | 0.00 |
OptiBiotix Health plc | OB3 | May 16, 2024 | 0.20 | -1.96 |
Oric Pharmaceuticals, Inc. | 4TZ | May 16, 2024 | 8.35 | -3.47 |
Oxford BioDynamics plc | LMQ | May 16, 2024 | 0.05 | -0.98 |
Oxford Biomedica | OXOA | May 16, 2024 | 3.72 | -0.53 |
Pharmaron Beijing Co Ltd | 17Q1 | May 16, 2024 | 1.23 | +0.82 |
Pharmaust Ltd. | ECQ | May 16, 2024 | 0.08 | -18.93 |
Philogen S.p.a. | 78Q | May 16, 2024 | 17.05 | 0.00 |
Physiomics | RVW1 | May 16, 2024 | 0.01 | +30.77 |
Polynovo Limited | MFJ | May 16, 2024 | 1.31 | +1.55 |
Poseida Therapeutics, Inc. | 2RZ | May 16, 2024 | 3.13 | +15.86 |
Pure Biologics S A | PQB | May 16, 2024 | 1.52 | 0.00 |
PureTech Health Plc | 0VQ | May 16, 2024 | 2.58 | +1.57 |
Quantum Genomics | 2QG | May 16, 2024 | 0.12 | +0.50 |
RECCE PHARMACEUTICALS Ordinary Fully Paid (Australia) | R9Q | May 16, 2024 | 0.34 | -2.29 |
Redx Pharma Plc | 0RX | May 16, 2024 | 0.17 | 0.00 |
RemeGen Co. Ltd. | REG | May 16, 2024 | 3.64 | +3.41 |
ReproCELL Incorporated | 6RC | May 16, 2024 | 0.57 | -1.71 |
Ryvu Therapeutics S.A. | 9Y4 | May 16, 2024 | 12.24 | +3.03 |
Sareum Holdings Plc | RYH0 | May 16, 2024 | 0.43 | -5.29 |
Scancell Hldgs Plc | SCP | May 16, 2024 | 0.10 | +16.36 |
Sensorion | RFM | May 16, 2024 | 0.69 | +1.47 |
Shanghai Haohai Biological Technology Co. Ltd | 5HB | May 16, 2024 | 4.90 | +0.41 |
Silence Therapeutics Plc - American Depository Share | XRP2 | May 16, 2024 | 19.50 | +5.41 |
Simcere Pharmaceutical Group Limited | S2P | May 16, 2024 | 0.65 | -1.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.